Globalization of Biosimilars

Globalization of Biosimilars is about the generic drugs impact on Global Biosimilar market, Cost and risk management, adopting innovative mechanisms such as risk-sharing arrangement, European market for Biosimilars. A growing global market for Biosimilars is gaining momentum in response to the expiration of patents for a number of key Biologics and consumer demand to reduce treatment costs. Thus, according to Research and Markets, the global biosimilar market, valued at $2 billion in 2012 is projected to reach $19.4 billion by 2018.

  • Global impact of Biosimilars over generics
  • Economic aspect towards Biosimilars
  • Biosimilars in global market
  • Investment and returns on Biosimilars
  • Cost and risk management
  • Adopting innovative mechanisms such as risk-sharing arrangement
  • European market for Biosimilars
  • Global P&R models for the Biosimilars and generics market

Related Conference of Globalization of Biosimilars

February 28-March 01, 2019 ANA Crowne Plaza |

Global Pharmaceutical and Pharma Industry Conference

Osaka, Japan
March 18-19, 2019

13th International Conference on Biosimilars and Biologics

Amsterdam | Netherlands
July 26-27, 2019

13th Asian Biologics and Biosimilars Congress

Mercure Albert Park | Melbourne, Australia

Globalization of Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in